Company: LRHC
Filing Date: 2025-09-30
Form Type: 424B3
Source: 0001213900-25-093998
Chunk: 45

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-30
Form: 424B3
Chunk 45
---
 during the Regular Trading Hours (as defined therein) applicable
to the relevant Pricing Period; and (C) an Extended Purchase Pricing Period being the lower of (i) the lowest price the common stock traded
during the Extended Trading Hours (as defined therein) on the trading day applicable to the relevant Pricing Period and (ii) the lowest
Extended Hourly VWAP (as defined therein) of the common shares during the trading day applicable to the relevant.

<div align='center'>25</div>

The proceeds from any sale of Advance Shares by the Company under the
Amended Facility Agreement may be used by the Company in the manner set forth in this Prospectus, including for working capital purposes
for the Company and its subsidiaries. However, neither the Company nor any of its subsidiaries directly or indirectly will use the proceeds
of the transactions contemplated in the Amended Facility Agreement to repay any advances or loans to any executives or employees of the
Company or any subsidiary or to make any payments in respect of any related party obligations, including without limitation any payables
or notes payable to related parties of the Company or any subsidiary.

The Company will control the timing and amount
of any sales of Advance Shares to the Selling Stockholder. Actual sales of Advance Shares under the Facility will depend on a variety of factors to be determined
by the Company from time to time, which may include, without limitation, market conditions, the trading price of the common stock and
determinations by the Company as to the appropriate sources of funding for its business and operational needs. The net proceeds under
the Facility to the Company will depend on the frequency and prices at which the Company sells Advance Shares to the Selling Stockholder.

The Selling Stockholder will not be required to subscribe for any Advance
Shares under the Amended Facility Agreement which, when aggregated with all other Shares then beneficially owned by the Selling Stockholder
and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act, and Rule 13d-3 promulgated thereunder), would result
in the beneficial ownership by the Selling Stockholder and its affiliates to exceed 4.99% (which the Selling Stockholder, upon notice
to the Company, may increase or decrease but in no event in excess of 9.99%) of the outstanding voting power or number of the Common Stock.
As of August 4, 2025, the Selling Stockholder beneficially owned no shares of our common stock.

The Amended Facility Agreement contains customary
representations